Clinical Trial Update: Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy [Phase 4]

View source ↗

Summary

Phase 4 study evaluating co-administration of pegloticase with methotrexate in patients with uncontrolled gout who previously failed pegloticase monotherapy. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Krystexxa (pegloticase) (pegloticase)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Amgen | Conditions: Uncontrolled Gout | Phase 4 | Status: COMPLETED | Results posted: 2023-10-10